Daewoong Pharmaceutical has voluntarily withdrawn its application for Nabota's 100-unit product approval in China, aiming to resubmit with expanded dosage options to meet regulatory and market demands.
#YonhapInfomax #DaewoongPharmaceutical #Nabota #ChinaApproval #BotulinumToxin #ProductWithdrawal #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=74601
Daewoong Pharmaceutical Voluntarily Withdraws Nabota Product Application in China

Daewoong Pharmaceutical has voluntarily withdrawn its application for Nabota's 100-unit product approval in China, aiming to resubmit with expanded dosage options to meet regulatory and market demands.

Yonhap Infomax
“The International Trademark Association (INTA) warns that compelling manufacturers to engrave French words on products may result in their withdrawal from the Quebec market.”
#QC #Quebec #Canada #EnglishLanguage #FrenchLanguage
#Bill96 #QuebecMarket #TrademarkAssociation #INTA #LanguageRegulations #ProductWithdrawal #InternationalTrademarkAssociation
https://the-14.com/potential-product-loss-bill-96s-impact-on-quebec/
Potential Product Loss: Bill 96’s Impact on Quebec | The-14

Bill 96 will make life harder for English-speaking Quebecers. Bill 96 has prompted protests, court challenges, and concerns from English-speaking groups.

The-14 Pictures
Potential Product Loss: Bill 96’s Impact on Quebec | The-14

Bill 96 will make life harder for English-speaking Quebecers. Bill 96 has prompted protests, court challenges, and concerns from English-speaking groups.

The-14 Pictures